Serge Belanger
Stock Analyst at Needham
(4.73)
# 703
Out of 4,673 analysts
972
Total ratings
50%
Success rate
14.5%
Average return
Main Sectors:
Stocks Rated by Serge Belanger
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OCUL Ocular Therapeutix | Maintained: Buy | $18 | $11.08 | +62.45% | 16 | Aug 17, 2026 | |
| CRMD CorMedix | Maintained: Buy | $15 | $8.20 | +82.93% | 36 | Aug 13, 2026 | |
| OMER Omeros | Maintained: Hold | n/a | $19.27 | - | 55 | Aug 13, 2026 | |
| LQDA Liquidia | Maintained: Buy | $70 → $110 | $68.62 | +60.30% | 72 | Aug 12, 2026 | |
| MANE Veradermics | Maintained: Buy | $164 | $102.82 | +59.50% | 3 | Aug 12, 2026 | |
| HRTX Heron Therapeutics | Maintained: Hold | n/a | $0.3182 | - | 62 | Aug 10, 2026 | |
| MLTX MoonLake Immunotherapeutics | Maintained: Buy | $30 | $15.76 | +90.36% | 26 | Aug 10, 2026 | |
| CYTK Cytokinetics | Maintained: Buy | $102 → $112 | $76.84 | +45.76% | 52 | Aug 7, 2026 | |
| AMPH Amphastar Pharmaceuticals | Maintained: Hold | $20 | $21.60 | -7.41% | 45 | Aug 7, 2026 | |
| XENE Xenon Pharmaceuticals | Maintained: Buy | $78 | $60.77 | +28.35% | 40 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $4.82 | - | 48 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 | $17.96 | +28.06% | 52 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $48 | $27.87 | +72.23% | 18 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 | $13.09 | +190.41% | 10 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $34 | $24.29 | +39.98% | 36 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $56 → $46 | $27.11 | +69.68% | 168 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $8.39 | - | 31 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $36 → $40 | $25.08 | +59.49% | 35 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $9.55 | +67.54% | 58 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 → $33 | $24.67 | +33.77% | 81 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.9066 | n/a | 9 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.5728 | n/a | 13 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $1.83 | n/a | 1 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.0075 | n/a | 2 | Jun 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $5 | $0.06405 | n/a | 3 | Aug 19, 2016 |
Ocular Therapeutix
Aug 17, 2026
Maintained: Buy
Price Target: $18
Current: $11.08
Upside: +62.45%
CorMedix
Aug 13, 2026
Maintained: Buy
Price Target: $15
Current: $8.20
Upside: +82.93%
Omeros
Aug 13, 2026
Maintained: Hold
Price Target: n/a
Current: $19.27
Upside: -
Liquidia
Aug 12, 2026
Maintained: Buy
Price Target: $70 → $110
Current: $68.62
Upside: +60.30%
Veradermics
Aug 12, 2026
Maintained: Buy
Price Target: $164
Current: $102.82
Upside: +59.50%
Heron Therapeutics
Aug 10, 2026
Maintained: Hold
Price Target: n/a
Current: $0.3182
Upside: -
MoonLake Immunotherapeutics
Aug 10, 2026
Maintained: Buy
Price Target: $30
Current: $15.76
Upside: +90.36%
Cytokinetics
Aug 7, 2026
Maintained: Buy
Price Target: $102 → $112
Current: $76.84
Upside: +45.76%
Amphastar Pharmaceuticals
Aug 7, 2026
Maintained: Hold
Price Target: $20
Current: $21.60
Upside: -7.41%
Xenon Pharmaceuticals
Aug 7, 2026
Maintained: Buy
Price Target: $78
Current: $60.77
Upside: +28.35%
Aug 7, 2026
Maintained: Hold
Price Target: n/a
Current: $4.82
Upside: -
Aug 7, 2026
Maintained: Buy
Price Target: $23
Current: $17.96
Upside: +28.06%
Aug 7, 2026
Maintained: Buy
Price Target: $48
Current: $27.87
Upside: +72.23%
Aug 7, 2026
Maintained: Buy
Price Target: $38
Current: $13.09
Upside: +190.41%
Aug 6, 2026
Maintained: Buy
Price Target: $34
Current: $24.29
Upside: +39.98%
Aug 6, 2026
Maintained: Buy
Price Target: $56 → $46
Current: $27.11
Upside: +69.68%
Aug 6, 2026
Maintained: Hold
Price Target: n/a
Current: $8.39
Upside: -
Aug 6, 2026
Rated: Buy
Price Target: $36 → $40
Current: $25.08
Upside: +59.49%
Aug 5, 2026
Maintained: Buy
Price Target: $16
Current: $9.55
Upside: +67.54%
Aug 5, 2026
Maintained: Buy
Price Target: $32 → $33
Current: $24.67
Upside: +33.77%
Oct 28, 2022
Rated: Hold
Price Target: n/a
Current: $0.9066
Upside: n/a
Oct 28, 2022
Rated: Hold
Price Target: n/a
Current: $0.5728
Upside: n/a
Nov 5, 2021
Maintained: Buy
Price Target: $22
Current: $1.83
Upside: n/a
Jun 26, 2017
Reiterated: Hold
Price Target: n/a
Current: $0.0075
Upside: n/a
Aug 19, 2016
Reiterated: Buy
Price Target: $11 → $5
Current: $0.06405
Upside: n/a